Grufity logoGrufity logo
StocksFundsScreenerSectorsWatchlists
WBA

WBA - Walgreens Boots Alliance Inc Stock Price, Fair Value and News

20.83USD+0.01 (+0.05%)Delayed as of 18 Mar 2024, 02:54 pm ET

Market Summary

WBA
USD20.83+0.01
Delayedas of 18 Mar 2024, 02:54 pm
0.05%

WBA Stock Price

View Fullscreen

WBA RSI Chart

WBA Valuation

Market Cap

18.0B

Price/Earnings (Trailing)

31.28

Price/Sales (Trailing)

0.13

EV/EBITDA

10.15

Price/Free Cashflow

-33.94

WBA Price/Sales (Trailing)

WBA Profitability

EBT Margin

-0.36%

Return on Equity

2.95%

Return on Assets

0.59%

Free Cashflow Yield

-2.95%

WBA Fundamentals

WBA Revenue

Revenue (TTM)

142.4B

Rev. Growth (Yr)

9.96%

Rev. Growth (Qtr)

3.63%

WBA Earnings

Earnings (TTM)

574.0M

Earnings Growth (Yr)

98.2%

Earnings Growth (Qtr)

62.78%

Breaking Down WBA Revenue

52 Week Range

20.5436.58
(Low)(High)

Last 7 days

-1.2%

Last 30 days

-5.5%

Last 90 days

3.6%

Trailing 12 Months

-39.1%

How does WBA drawdown profile look like?

WBA Financial Health

Current Ratio

0.66

Debt/Equity

0.39

Debt/Cashflow

0.2

WBA Investor Care

Dividend Yield

7.54%

Dividend/Share (TTM)

1.68

Buy Backs (1Y)

0.01%

Diluted EPS (TTM)

0.66

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2023133.3B136.1B139.1B142.4B
2022135.9B134.5B132.7B132.2B
2021125.0B128.6B132.5B135.0B
2020129.8B125.6B122.0B123.5B
2019136.1B136.4B136.9B133.0B
2018124.0B128.2B131.5B134.6B
2017116.1B116.7B118.2B120.5B
2016116.5B117.2B117.4B116.8B
201584.6B94.0B103.4B112.9B
201474.3B75.3B76.4B77.6B
20130072.2B73.3B

Tracking the Latest Insider Buys and Sells of Walgreens Boots Alliance Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Mar 01, 2024
brown tracey d
acquired
-
-
11,219
evp, pres., walgreens retail
Mar 01, 2024
mahajan manmohan
acquired
-
-
101,874
evp and global cfo
Mar 01, 2024
fabbri beth amber l.
acquired
-
-
14,052
chief corp. affairs officer
Mar 01, 2024
heckman todd
acquired
-
-
12,541
svp, global controller and cao
Jan 29, 2024
jarrett valerie b
bought
99,992
22.44
4,456
-
Jan 16, 2024
schlichting nancy m
sold
-350,567
23.05
-15,209
-
Jan 05, 2024
wentworth timothy c
bought
242,220
24.222
10,000
chief executive officer
Nov 10, 2023
gates richard p.
sold
-20,450
20.45
-1,000
svp, chief pharmacy officer
Nov 01, 2023
sample neal j.
acquired
-
-
193,767
evp, chief information officer
Nov 01, 2023
brown tracey d
sold (taxes)
-85,100
21.08
-4,037
evp, pres., walgreens retail

1–10 of 50

Which funds bought or sold WBA recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Mar 13, 2024
MONECO Advisors, LLC
sold off
-100
-219,300
-
-%
Mar 12, 2024
PVG ASSET MANAGEMENT CORP
new
-
371,989
371,989
1.80%
Mar 11, 2024
VANGUARD GROUP INC
reduced
-4.08
243,132,000
2,170,790,000
0.05%
Mar 11, 2024
Wahed Invest LLC
added
9.38
70,656
319,299
0.09%
Mar 08, 2024
ICA Group Wealth Management, LLC
new
-
17,181
17,181
-%
Mar 08, 2024
TRUST CO OF VERMONT
added
21.19
8,875
29,870
-%
Mar 05, 2024
True Vision MN LLC
new
-
660,766
660,766
0.53%
Mar 04, 2024
Fortis Group Advisors, LLC
added
100
2,998
5,222
-%
Mar 04, 2024
Northwest Bank & Trust Co
new
-
15,666
15,666
0.01%
Mar 01, 2024
GOLDMAN SACHS GROUP INC
added
171
165,905,000
241,690,000
0.02%

1–10 of 45

Are Funds Buying or Selling WBA?

Are funds buying WBA calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own WBA
No. of Funds

Unveiling Walgreens Boots Alliance Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
9.62%
83,138,208
SC 13G/A
Jan 29, 2024
state street corp
6.28%
54,285,227
SC 13G/A
Jan 26, 2024
blackrock inc.
7.6%
65,892,675
SC 13G/A
Oct 10, 2023
vanguard group inc
10.04%
86,673,303
SC 13G/A
Feb 09, 2023
vanguard group inc
7.13%
61,519,967
SC 13G/A
Feb 07, 2023
state street corp
6.68%
57,573,619
SC 13G/A
Jan 31, 2023
blackrock inc.
7.0%
60,606,871
SC 13G/A
Feb 14, 2022
state street corp
5.45%
47,095,044
SC 13G/A
Feb 07, 2022
blackrock inc.
6.4%
55,032,519
SC 13G/A
Feb 11, 2021
state street corp
5.43%
46,922,371
SC 13G

Recent SEC filings of Walgreens Boots Alliance Inc

View All Filings
Date Filed Form Type Document
Mar 15, 2024
3
Insider Trading
Mar 05, 2024
4
Insider Trading
Mar 05, 2024
4
Insider Trading
Mar 05, 2024
4
Insider Trading
Mar 05, 2024
4
Insider Trading
Feb 13, 2024
SC 13G/A
Major Ownership Report
Feb 09, 2024
4
Insider Trading
Feb 09, 2024
SC 13D/A
13D - Major Acquisition
Feb 08, 2024
8-K
Current Report
Feb 07, 2024
144
Notice of Insider Sale Intent

What is the Fair Value of WBA?

Loading...
Disclaimer: Conduct thorough research and seek guidance from a certified financial advisor prior to finalizing any investment choices.

Peers (Alternatives to Walgreens Boots Alliance Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
381.0B
93.0B
-3.60% -2.76%
10.84
4.47
6.46% 95.94%
307.8B
60.1B
7.72% 18.52%
843.2
5.12
1.40% -97.49%
157.8B
46.5B
-3.76% -37.06%
-113.63
3.39
42.59% -114.62%
144.1B
28.2B
-7.44% 18.02%
21.45
5.11
7.09% 2.52%
91.8B
27.1B
-17.13% -16.65%
16.21
3.39
-0.60% 23.36%
15.0B
15.8B
15.02% 26.90%
-26.11
0.95
6.17% 76.47%
MID-CAP
4.8B
1.7B
14.11% 18.79%
13.5
2.89
49.61% 324.78%
4.1B
4.7B
-2.94% -9.06%
-324.06
0.88
4.58% 90.97%
3.4B
8.8B
-0.23% 18.85%
-5.68
0.38
7.79% -163.11%
2.1B
644.4M
-0.28% 70.16%
15.05
3.21
29.14% 50.51%
SMALL-CAP
1.3B
700.5M
2.67% -
-0.9
1.83
16.26% -147.49%
25.4M
70.0M
-0.88% -54.80%
0.37
0.34
-19.54% 888.31%
19.9M
-
58.23% -28.98%
-1.08
0.22
2882.68% -138.52%
15.4M
111.1M
-6.33% -18.68%
-0.97
0.14
-10.43% 84.90%
1.4M
20.0M
-35.83% -91.10%
-0.1
0.07
137.71% 66.04%

Walgreens Boots Alliance Inc News

Latest updates
MarketBeat • 5 minutes ago
Seeking Alpha • 15 Mar 2024 • 04:15 pm
InvestorsObserver • 14 Mar 2024 • 06:59 pm

Walgreens Boots Alliance Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue3.6%36,70735,42235,41534,86233,38232,44932,59733,75633,90134,26234,03032,77931,43830,37130,36431,33629,91233,95434,59134,52833,793
Gross Profit4.6%6,7716,4756,5887,0556,9536,4106,5727,7087,5747,5037,1536,7816,6306,3245,9597,0176,7777,2287,4537,7547,641
  S&GA Expenses-2.0%6,8516,9907,1236,93413,1587,3207,0196,5656,3916,6506,1166,0295,7925,5777,8845,9096,2624,7236,2356,3206,280
EBITDA Margin192.2%0.02*-0.02*-0.02*-0.02*-0.02*0.05*0.06*0.07*0.07*0.04*0.03*0.01*0.01*0.02*-------
Interest Expenses-36.3%99.0015617314111010610810086.0088.00545137136147148156166121187181161
Income Taxes51.0%-74.00-151-33070.00-1,447-235-24217227558624642.00-207206-43.0014932.0015.00156226180
Earnings Before Taxes4.4%-358-374-382607-5,270-758-18.009473,814907749946-607460-1,8621,0088825401,1981,3561,265
EBT Margin90.9%0.00*-0.04*-0.04*-0.04*-0.04*0.03*0.04*0.05*0.05*0.02*0.01*-0.01*-0.01*0.00*-------
Net Income62.8%-67.00-180118703-3,721-4152898833,5806271,1971,026-308373-1,7089468456771,0251,1561,123
Net Income Margin118.2%0.00*-0.02*-0.02*-0.02*-0.02*0.03*0.04*0.05*0.05*0.02*0.02*0.00*-0.01*0.00*-------
Free Cashflow-241.8%-787555-545248-117-4071,2586696458671,4451,1007641,674-------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets1.2%97,82396,62898,605100,47992,87590,12492,75992,68396,50781,28591,92090,92089,16787,17486,44490,00390,80767,59868,58670,43469,941
  Current Assets11.9%17,34515,50316,54217,68919,52316,90218,87216,82420,31415,81426,60726,08421,08418,07318,32618,90919,60418,70019,02119,85120,083
    Cash Equivalents6.1%7847398711,0884,3142,5584,5412,0274,2685591,8031,3111,3397469439881,0001,2077687921,183
  Inventory14.5%9,4548,2578,1648,7579,3228,3538,5208,9479,4758,1598,3338,54111,1807,9179,5639,65210,5369,3339,87410,18810,976
  Net PPE----------------13,48213,62013,47813,71713,82813,821
  Goodwill0.0%28,18428,18728,37192.0022,58222,28021,90121,9588,16612,42112,49312,46815,29912,01314,94816,78816,80013,54216,71717,027-
Liabilities2.8%70,06668,14069,08670,88268,13759,71761,60261,00463,14157,14569,01468,98568,42666,038-------
  Current Liabilities6.4%26,11624,53526,17028,22828,03622,58324,06722,69924,44722,05434,47531,24630,37927,07026,64928,66229,49425,76925,06025,30325,099
  Short Term Borrowings82.1%1,6709173,0614,2223,9381,0592,7872,1052,6471,3057,9635,1615,2453,2654,3795,9846,2255,7385,4835,3564,344
  Long Term Debt-6.9%7,5858,1458,8418,8207,78910,61510,67011,20311,1997,6757,73210,99810,97312,20312,11110,62510,62811,09812,12712,68511,646
    LT Debt, Non Current-6.9%7,5858,1458,8418,8207,78910,61510,67011,20311,1997,6757,73210,99810,97312,20312,11110,62510,62811,09812,12712,68511,646
Shareholder's Equity-2.7%19,48120,02021,06329,43924,58229,36630,38230,86730,57923,82222,59621,62520,56321,13621,32324,33424,31424,15224,77125,41326,263
  Retained Earnings-1.5%32,57333,05833,65433,95233,66437,80138,63238,75738,28635,12134,90834,11633,49534,21034,24436,35135,81035,81535,54734,92834,168
  Additional Paid-In Capital-0.4%10,61710,66110,66710,62910,47710,95011,02910,97310,96610,98810,97110,91610,87610,76110,72610,68910,64810,63910,60510,57110,522
Shares Outstanding0.0%863863863863864864864864866865865865865879-------
Minority Interest-2.3%8,1078,3028,2968,2474,0064,091--4,316402495514506498586615653641638643654
Float----25,400-23,200-----23,200---33,500---54,500-
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations-127.0%-2811,039-20.0074649386.001,6291,0851,0991,2451,7541,3611,1952,0869141,4231,0612,3792,020735460
  Share Based Compensation37.8%51.0037.0055.0071.0022212596.0013535.0035.0050.0034.0036.0036.0034.0039.0028.0032.0024.0036.0027.00
Cashflow From Investing-45.2%85.00155334-5,4411,858198919-223-1,9585,41315.00-1,097-259-637-43.00-215-402-738-523-411-635
Cashflow From Financing112.7%186-1,460-1,1932,365-599-2,252-16.00-3,1083,877-7,180-1,209-295-352-1,649-913-1,219-866-1,474-1,458-505390
  Dividend Payments0%415415415414415408418420413405404403405487403447410399403419422
  Buy Backs-69.00---150--33.00154---1102154614404734346132,201912

WBA Income Statement

2023-11-30
CONSOLIDATED CONDENSED STATEMENTS OF EARNINGS - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Nov. 30, 2023
Nov. 30, 2022
Income Statement [Abstract]  
Sales$ 36,707$ 33,382
Cost of sales29,93726,429
Gross profit6,7716,953
Selling, general and administrative expenses6,85113,158
Equity earnings in Cencora4253
Operating loss(39)(6,151)
Other (expense) income, net(220)992
Loss before interest and income tax benefit(259)(5,159)
Interest expense, net99110
Loss before income tax benefit(358)(5,270)
Income tax benefit(74)(1,447)
Post-tax earnings from other equity method investments67
Net loss(278)(3,816)
Net loss attributable to non-controlling interests(210)(94)
Net loss attributable to Walgreens Boots Alliance, Inc.$ (67)$ (3,721)
Earnings Per Share, Basic [Abstract]  
Total (in dollars per share)$ (0.08)$ (4.31)
Earnings Per Share, Diluted [Abstract]  
Total (in dollars per share)$ (0.08)$ (4.31)
Weighted average common shares outstanding:  
Basic (in shares)863.0863.6
Diluted (in shares)863.0863.6

WBA Balance Sheet

2023-11-30
CONSOLIDATED CONDENSED BALANCE SHEETS - USD ($)
$ in Millions
Nov. 30, 2023
Aug. 31, 2023
Current assets:  
Cash and cash equivalents$ 784$ 739
Accounts receivable, net5,9725,381
Inventories9,4548,257
Other current assets1,1341,127
Total current assets17,34515,503
Non-current assets:  
Property, plant and equipment, net11,17611,587
Operating lease right-of-use assets21,70821,667
Goodwill28,18428,187
Intangible assets, net13,27813,635
Equity method investments (see Note 5)3,4003,497
Other non-current assets2,7322,550
Total non-current assets80,47881,125
Total assets97,82396,628
Current liabilities:  
Short-term debt1,670917
Trade accounts payable (see Note 16)13,59312,635
Operating lease obligations2,3502,347
Accrued expenses and other liabilities8,2268,426
Income taxes276209
Total current liabilities26,11624,535
Non-current liabilities:  
Long-term debt7,5858,145
Operating lease obligations22,13222,124
Deferred income taxes1,2791,318
Accrued litigation obligations6,3666,261
Other non-current liabilities6,5895,757
Total non-current liabilities43,95143,605
Commitments and contingencies (see Note 10)
Total liabilities70,06668,140
Redeemable non-controlling interests169167
Equity:  
Preferred stock $.01 par value; authorized 32 million shares, none issued00
Common stock $.01 par value; authorized 3.2 billion shares; issued 1,172,513,618 at November 30, 2023 and August 31, 20231212
Paid-in capital10,61710,661
Retained earnings32,57333,058
Accumulated other comprehensive loss(2,995)(2,993)
Treasury stock, at cost; 310,346,648 shares at November 30, 2023 and 308,839,832 shares at August 31, 2023(20,725)(20,717)
Total Walgreens Boots Alliance, Inc. shareholders’ equity19,48120,020
Non-controlling interests8,1078,302
Total equity27,58828,322
Total liabilities, redeemable non-controlling interests and equity$ 97,823$ 96,628
WBA
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. The company operates under the Walgreens and Duane Reade brands in the United States. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. The company operates retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
 CEO
 WEBSITEwww.walgreensbootsalliance.com
 EMPLOYEES65535

Walgreens Boots Alliance Inc Frequently Asked Questions


What is the ticker symbol for Walgreens Boots Alliance Inc? What does WBA stand for in stocks?

WBA is the stock ticker symbol of Walgreens Boots Alliance Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Walgreens Boots Alliance Inc (WBA)?

As of Fri Mar 15 2024, market cap of Walgreens Boots Alliance Inc is 17.95 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of WBA stock?

You can check WBA's fair value in chart for subscribers.

What is the fair value of WBA stock?

You can check WBA's fair value in chart for subscribers. The fair value of Walgreens Boots Alliance Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Walgreens Boots Alliance Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for WBA so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Walgreens Boots Alliance Inc a good stock to buy?

The fair value guage provides a quick view whether WBA is over valued or under valued. Whether Walgreens Boots Alliance Inc is cheap or expensive depends on the assumptions which impact Walgreens Boots Alliance Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for WBA.

What is Walgreens Boots Alliance Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Mar 15 2024, WBA's PE ratio (Price to Earnings) is 31.28 and Price to Sales (PS) ratio is 0.13. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. WBA PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Walgreens Boots Alliance Inc's stock?

In the past 10 years, Walgreens Boots Alliance Inc has provided -0.08 (multiply by 100 for percentage) rate of return.